Position in MRK
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$9,467,880
+$936,673 QoQ
Shares Held
73,680
+3.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#761
of 3,769 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Global X Japan Co., Ltd. holds $85,923,287 across 8 Drug Manufacturers - General names. MRK ranks #4 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
119,340 | $30,030,717 | |
| 2 | JNJ |
Johnson & Johnson
|
83,998 | $21,332,972 | |
| 3 | AMGN |
Amgen Inc
|
27,085 | $9,808,020 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
73,680 | $9,467,880 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
60,937 | $7,698,780 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
90,137 | $5,193,693 | |
| 7 | LLY |
ELI LILLY & Co
|
1,974 | $2,367,675 | |
| 8 | BIIB |
Biogen Inc.
|
109 | $23,550 |
All Filings in MRK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,467,880 | 73,680 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $8,531,207 | 70,922 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $7,146,311 | 67,892 | Shares | Sole | 2026-01-13 | |
| No filing history on record for this holder in this stock. | ||||||